Search for: "BASS v. SMITH" Results 1 - 20 of 50
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
23 Jun 2023, 1:22 pm by Gia Kokotakis
Tyler McBrien shared a motion submitted by Special Counsel Jack Smith for a protective order to limit the disclosure of discovery information in the case of United States of America v. [read post]
23 Sep 2022, 4:00 am by Jim Sedor
Spending in election cycles by corporations and the ultrawealthy through so-called dark money groups has skyrocketed since the 2010 Supreme Court decision Citizens United v. [read post]
15 Jan 2019, 3:15 am by Peter Groves
Ever since Lord Diplcok's speech in Catnic v Hill & Smith [1981] FSR 60, [1982] RPC 183 (HL) we have been familiar with the idea of a purposive approach to interpreting patent claims - considering what the applicant had in mind, the spirit of the claims, rather than the precise words used. [read post]
25 Jul 2017, 5:32 pm
However, when hedge fund trader Kyle Bass used such a strategy of shorting pharmaceutical companies after challenging their patents, he caused outcry from the pharmaceutical industry and some Congresspersons. [read post]
7 Mar 2017, 8:19 am by Edward Smith
Growth Plate Fractures in Children Because your child’s bones are still growing, they are particularly vulnerable to a type of fracture known as a growth plate fracture. [read post]
10 May 2016, 10:45 am
Boston Scientific Corp., 631 F.3d 762 (5thCir. 2011); Bass v. [read post]
28 Sep 2015, 3:35 am
| IP: When innovation is the answer to a spiritual funkNever Too Late 63 [week ending on Sunday 13 September] - Fair compensation in reprography and private copying: the ECS’ version | Substitute sellers | Teva UK Ltd & Another v Leo Pharma | Evidence-based IP policy | KitKat case | UK IPO’s priorities | UK IPO’s website vs complete copyright legislation | Patent Attorney Qualifications | Mylan and Actavis v… [read post]
20 Sep 2015, 4:08 pm
******************PREVIOUSLY, ON NEVER TOO LATE Never Too Late 63 [week ending on Sunday 13 September] - Fair compensation in reprography and private copying: the ECS’ version | Substitute sellers | Teva UK Ltd & Another v Leo Pharma | Evidence-based IP policy | KitKat case | UK IPO’s priorities | UK IPO’s website vs complete copyright legislation | Patent Attorney Qualifications | Mylan and Actavis v… [read post]